ABBV Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

212.350

Open

209.660

VWAP

209.52

Vol

8.99M

Mkt Cap

368.57B

Low

207.820

Amount

1.88B

EV/EBITDA(TTM)

14.65

Total Shares

1.77B

431.94B

EV/OCF(TTM)

22.70

P/S(TTM)

6.06

AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Events Timeline

(ET)

2026-04-13

07:10:00

CollPlant Terminates Development Agreement with AbbVie, Looks Ahead to 2026

2026-04-12 (ET)

2026-04-12

12:40:00

AbbVie to Present IMGN853-0420 Trial Results at SGO Annual Meeting

2026-04-09 (ET)

2026-04-09

10:20:00

French President Calls for Middle East Ceasefire, Trump Involved

2026-04-08 (ET)

2026-04-08

16:10:00

Major Averages Surge on U.S.-Iran Ceasefire Announcement

2026-04-08

12:20:00

AbbVie Sues Trump Administration for Clearer Definition of Eligible Patients in Discount Drug Program

News

5.0

04-18Fool

Three Stocks to Hold for 20 Years

5.0

04-17Fool

Investment Opportunities in Psychedelic Therapy

5.0

04-17NASDAQ.COM

Investment Opportunities in Psychedelic Therapy

2.0

04-16Fool

AbbVie's Stock Pullback Represents a Long-Term Buying Opportunity

6.5

04-15NASDAQ.COM

Analysis of AbbVie's Shareholding Changes

8.0

04-15Fool

Three High-Yield Stocks for Investors

18 Analyst Rating

Wall Street analysts forecast ABBV stock price to rise

12 Buy

6 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

223.00

Averages

252.00

High

289.00

Current: 0.000

Low

223.00

Averages

252.00

High

289.00

Evercore ISI

Outperform

maintain

$233 -> $232

AI Analysis

2026-04-13

Reason

Evercore ISI

Price Target

$233 -> $232

AI Analysis

2026-04-13

maintain

Outperform

Reason

Evercore ISI lowered the firm's price target on AbbVie to $232 from $233 and keeps an Outperform rating on the shares. The analyst adjusted estimates in a Q1 preview note.

Guggenheim

Vamil Divan

Buy

maintain

$242 -> $249

2026-04-10

Reason

Guggenheim

Vamil Divan

Price Target

$242 -> $249

2026-04-10

maintain

Buy

Reason

Guggenheim analyst Vamil Divan raised the firm's price target on AbbVie to $249 from $242 and keeps a Buy rating on the shares. The firm has "modestly adjusted" quarterly estimates based on its latest review of IQVIA script data and its recent check-in with the investor relations team ahead of the company's Q1 earnings release on April 29.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ABBV

Unlock Now

Valuation Metrics

The current forward P/E ratio for AbbVie Inc (ABBV.N) is 14.37, compared to its 5-year average forward P/E of 13.43. For a more detailed relative valuation and DCF analysis to assess AbbVie Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

13.43

Current PE

14.37

Overvalued PE

16.23

Undervalued PE

10.64

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.77

Current EV/EBITDA

13.18

Overvalued EV/EBITDA

15.87

Undervalued EV/EBITDA

9.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

4.96

Current PS

5.10

Overvalued PS

5.76

Undervalued PS

4.16

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

myse

Intellectia · 1131 candidates

Market Cap: >= 2.00BPrice: >= $5.00List Exchange: XNYSMonthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.88T

BRK.A

Berkshire Hathaway Inc

1.02T

BRK.B

Berkshire Hathaway Inc

1.02T

WMT

Walmart Inc

995.12B

LLY

Eli Lilly and Co

854.11B

JPM

JPMorgan Chase & Co

831.35B

rsi_category: ['oversold', 'moderate'] big cap

Intellectia · 862 candidates

Market Cap Category: mega, largeRsi Category: oversold, moderate

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.83T

GOOG

Alphabet Inc

4.05T

AAPL

Apple Inc

3.91T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.95T

META

Meta Platforms Inc

1.70T

TSLA

Tesla Inc

1.47T

RSI < 40 big cap

Intellectia · 862 candidates

Market Cap Category: mega, largeRsi Category: oversold, moderate

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.83T

GOOG

Alphabet Inc

4.05T

AAPL

Apple Inc

3.91T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.95T

META

Meta Platforms Inc

1.70T

TSLA

Tesla Inc

1.47T

Find me a trade a d take i

Intellectia · 85 candidates

Region: USVolume: >= -100List Exchange: XNAS, XNYS, XASEMoving Average Relationship: PriceCrossAboveMA20, PriceCrossDownMA20, PriceAboveMA20, PriceAboveMA200, PriceBelowMA20, PriceBelowMA200Is Optionable: TrueSupport Resistance Relationship: PriceBreakResistance, PriceFallBelowSupport, PriceAroundResistance, PriceAroundSupportOne Day Rise Prob: 0 - 100One Day Predict Return: 0.0% - 100.0%One Week Rise Prob: 0 - 100One Week Predict Return: 0.0% - 100.0%Monthly Average Dollar Volume: >= -100Macd: positive, negative, bearish, bullish

Ticker

Name

Market Cap$

ABBV

AbbVie Inc

362.35B

ABT

Abbott Laboratories

182.61B

ARM

Arm Holdings PLC

145.38B

BUD

Anheuser-Busch Inbev SA

133.72B

BTI

British American Tobacco plc

125.56B

ADBE

Adobe Inc

100.95B

top stocks in health sector

Intellectia · 38 candidates

Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%

Ticker

Name

Market Cap$

LLY

Eli Lilly and Co

866.87B

ABBV

AbbVie Inc

364.65B

AZN

AstraZeneca PLC

293.00B

MRK

Merck & Co Inc

282.35B

UNH

UnitedHealth Group Inc

254.55B

AMGN

Amgen Inc

188.63B

best stocks to swing trade

Intellectia · 1222 candidates

Region: USRsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $-5.00 - $40.00Monthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.94T

XOM

Exxon Mobil Corp

635.43B

COST

Costco Wholesale Corp

448.66B

ABBV

AbbVie Inc

410.36B

Procter & Gamble Co

390.70B

General Electric Co

358.95B

what blue chip

Intellectia · 59 candidates

Market Cap: >= 80.00BDividend Yield Ttm: 1 - 6Net Margin: >= 5.00Return On Equity: >= 10.0%Is Index Component: GSPC, DJI

Ticker

Name

Market Cap$

JPM

JPMorgan Chase & Co

809.92B

XOM

Exxon Mobil Corp

635.43B

JNJ

Johnson & Johnson

598.69B

ABBV

AbbVie Inc

410.36B

Procter & Gamble Co

390.70B

Home Depot Inc

379.01B

Stocks with same technicals as DHR

Intellectia · 52 candidates

Market Cap: >= 150.00BRegion: USRsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Is Index Component: GSPC

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.31T

AAPL

Apple Inc

3.88T

GOOG

Alphabet Inc

3.77T

AVGO

Broadcom Inc

1.52T

TSLA

Tesla Inc

1.51T

WMT

Walmart Inc

1.02T

which are the s&p 500 companies

Intellectia · 476 candidates

Is Index Component: GSPC

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.61T

AAPL

Apple Inc

3.88T

GOOG

Alphabet Inc

3.81T

MSFT

Microsoft Corp

2.95T

AMZN

Amazon.com Inc

2.26T

META

Meta Platforms Inc

1.66T

medical and tech

Intellectia · 1801 candidates

Sector: Financial Technology (Fintech) & Infrastructure, Healthcare, Healthcare Services & Equipment, Technology, Technology EquipmentList Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.57T

AAPL

Apple Inc

3.88T

GOOG

Alphabet Inc

3.68T

MSFT

Microsoft Corp

2.97T

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.88T

META

Meta Platforms Inc

1.63T

Whales Holding ABBV

Qube Research & Technologies Ltd

Edgestream Partners, L.P.

Distillate Capital Partners LLC

Bank J. Safra Sarasin AG

AGF Management Limited

Acadian Asset Management LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is AbbVie Inc (ABBV) stock price today?

The current price of ABBV is 208.38 USD — it has decreased -0.29

What is AbbVie Inc (ABBV)'s business?

What is the price predicton of ABBV Stock?

Wall Street analysts forecast ABBV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABBV is252.00 USD with a low forecast of 223.00 USD and a high forecast of 289.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is AbbVie Inc (ABBV)'s revenue for the last quarter?

AbbVie Inc revenue for the last quarter amounts to 16.62B USD, increased 10.04

What is AbbVie Inc (ABBV)'s earnings per share (EPS) for the last quarter?

AbbVie Inc. EPS for the last quarter amounts to 1.02 USD, decreased -5200.00

How many employees does AbbVie Inc (ABBV). have?

AbbVie Inc (ABBV) has 57000 emplpoyees as of April 19 2026.

What is AbbVie Inc (ABBV) market cap?

Today ABBV has the market capitalization of 368.57B USD.

ABBV Overview

ABBV Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding ABBV

Trading Trends

People Also Watch

Frequently Asked Questions

What is AbbVie Inc (ABBV) stock price today?

What is AbbVie Inc (ABBV)'s business?

What is the price predicton of ABBV Stock?

What is AbbVie Inc (ABBV)'s revenue for the last quarter?

What is AbbVie Inc (ABBV)'s earnings per share (EPS) for the last quarter?

How many employees does AbbVie Inc (ABBV). have?

What is AbbVie Inc (ABBV) market cap?